# Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus

> **NCT03589443** · PHASE1 · COMPLETED · sponsor: **University of Michigan** · enrollment: 27 (actual)

## Conditions studied

- Barrett Esophagus

## Interventions

- **DRUG:** Multiplexed heptapeptides

## Key facts

- **NCT ID:** NCT03589443
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-10
- **Primary completion:** 2019-02-04
- **Final completion:** 2019-02-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589443, "Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT03589443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*